Summary of the conclusions

Holgate, S. T., Church, M. K., Howarth, P. H., Simons, F. E. R., Campbell, A., Dunn, N., Routledge, Philip Alexander, Hindmarch, I., Timmermann, H., Camm, J., Friedmann, P., Canonica, W., Scadding, G., Devalia, J. and Renwick, A. 1999. Summary of the conclusions. Clinical and Experimental Allergy 29 (S3) , iv-vi. 10.1046/j.1365-2222.1999.00001.x-i1

Full text not available from this repository.

Abstract

From this Workshop it became clear that in recent years appreciable improvements in the efficacy and safety of histamine H1 antagonists have been achieved. Also, there has accumulated considerable new knowledge about the mechanisms of action of these drugs, both with respect to their interaction with the H1 receptor and with other cellular components. Amongst these are actions that relate to potential side-effects. The new understanding of molecular mechanisms is likely to provide the basis for further significant improvements in antihistamines as a drug group, through molecular-based design. Until this objective has been realized, the use of the term ‘third-generation’ antihistamine should be abandoned...

Item Type:	Article
Status:	Published
Schools:	Schools > Pharmacy
Subjects:	R Medicine > RS Pharmacy and materia medica
Additional Information:	Summary of the conclusions of the Workshop on Antihistamines: back to the Future. Held by The British Society for Allergy and Clinical Immunology.
Publisher:	Wiley-Blackwell
ISSN:	0954-7894
Last Modified:	04 Jun 2017 03:29
URI:	https://orca.cardiff.ac.uk/id/eprint/21947

Citation Data

Cited 3 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item